MetLife (NYSE: MET) risk chief sells 21,312 shares after option exercises
Rhea-AI Filing Summary
MetLife EVP & Chief Risk Officer Marlene Debel reported option exercises and share sales in common stock. On June 1, 2026, she exercised employee stock options to acquire 10,712 shares at $45.50 and 10,600 shares at $46.85 per share. The same day, she completed an open‑market sale of 21,312 shares at a weighted average price of $81.5889, with individual trade prices between $81.57 and $81.65. Following these transactions, she directly owns 154,380 shares of MetLife common stock.
Positive
- None.
Negative
- None.
Insights
Routine option exercises paired with a moderate insider sale.
EVP & Chief Risk Officer Marlene Debel exercised employee stock options for a total of 21,312 shares at strike prices of $45.50 and $46.85, then sold the same number of shares in open‑market trades at a weighted average of $81.5889.
The filing shows a classic exercise‑and‑sell pattern, converting option value into cash while maintaining a substantial remaining equity stake of 154,380 common shares. With 0% reported remaining employee stock options in this excerpt, the visible derivative position tied to these grants has been fully exercised.
This activity represents a net share sale but still leaves a large direct holding, suggesting ongoing alignment with shareholders. The trades were executed across multiple prices between $81.57 and $81.65; no Rule 10b5‑1 trading plan is referenced in the provided text.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Options (right to buy) | 10,600 | $0.00 | -- |
| Exercise | Employee Stock Options (right to buy) | 10,712 | $0.00 | -- |
| Exercise | Common Stock | 10,600 | $46.85 | $497K |
| Exercise | Common Stock | 10,712 | $45.50 | $487K |
| Sale | Common Stock | 21,312 | $81.5889 | $1.74M |
Footnotes (1)
- The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $81.57 to $81.65, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. The options became exercisable in three substantially equal installments on February 28, 2018, 2019, and 2020. The options became exercisable in three substantially equal installments on March 2, 2019, 2020, and 2021.